Serum MBP immunoreactivity and immunoglobulin level as markers of tumour type


Forty three patients, admitted to the department of Neurological Surgery for management of central nervous system tumours, were studied pre-operatively for serum myelin basic protein immunoreactivity as a marker of central nervous system lesion and for circulating immunoglobulins and complement (C3) levels. Myelin basic protein concentration did not appear… (More)
DOI: 10.1007/BF00177900


2 Figures and Tables